Urocortin

Also known as: UCN, P55089

**Mechanism of Action** Urocortin (UCN) is a 40-amino acid peptide belonging to the corticotropin-releasing factor (CRF) family, binding with high affinity to CRF receptor type 2 (CRF-R2) and, to a lesser extent, CRF-R1. It activates Gs-protein-coupled signaling, increasing intracellular cAMP and downstream protein kinase A (PKA) activity. Urocortin modulates the hypothalamic-pituitary-adrenal (HPA) axis, autonomic nervous system, and peripheral stress responses, including regulation of appetite, cardiovascular function, and immune modulation. Its effects are tissue-specific, with CRF-R2 predominantly expressed in peripheral tissues (e.g., heart, skeletal muscle, gastrointestinal tract) and discrete brain regions. **Key Research Findings** Preclinical studies demonstrate urocortin’s role in stress adaptation, including suppression of food intake, enhancement of anxiety-like behaviors, and modulation of cardiovascular function (e.g., vasodilation, positive inotropy). In rodent models, urocortin administration reduces inflammation and protects against ischemia-reperfusion injury in cardiac and cerebral tissues. It also influences energy balance by increasing thermogenesis and lipid oxidation. However, its anorexigenic and stress-related effects limit therapeutic translation. Experimental status indicates ongoing investigation into analogs with improved receptor selectivity and pharmacokinetics. **Clinical Relevance** Urocortin’s potential applications include stress-related disorders (e.g., anxiety, depression), metabolic syndrome, and cardiovascular protection. No approved human therapies exist; research remains preclinical. Challenges include off-target CRF-R1 activation (promoting anxiety) and short half-life. Future directions focus on CRF-R2-selective agonists for conditions like heart failure or obesity, though safety and efficacy data are lacking. For research purposes only — not medical advice.

Key data

Mechanism of action

Hormone that plays a central role in whole body adaptation to stress (PubMed:20966082, PubMed:24290358, PubMed:32004470, PubMed:36335102, PubMed:8612563). Released by the hypothalamus primarily in response to physical or psychological stress and acts by binding to CRH receptors CRHR1 and CRHR2 (PubMed:24290358, PubMed:26350463, PubMed:32004470, PubMed:36335102, PubMed:8612563). UCN-dependent signaling is a primary mediator of the neuroendocrine, autonomic (fight-or-flight) and behavioral responses to stress, acting as a key regulator of adaptation by activating the hypothalamus-pituitary-adrenal axis, leading to corticotropin hormone (ACTH) production (PubMed:8612563). Plays a role in the establishment of normal hearing thresholds (By similarity). Reduces food intake and regulates ghrelin levels in gastric body and plasma (By similarity)

Research & studies

Frequently asked questions

Related peptides